SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-09-202769
Filing Date
2009-10-02
Accepted
2009-10-02 16:01:57
Documents
4
Period of Report
2009-11-11
Effectiveness Date
2009-10-02

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 313392
2 GRAPHIC g62605g02u98.jpg GRAPHIC 10005
3 GRAPHIC g62605g70l52.jpg GRAPHIC 6593
4 GRAPHIC g62605pcp1.jpg GRAPHIC 16032
  Complete submission text file 0001193125-09-202769.txt   360538
Mailing Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381
Business Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33004 | Film No.: 091102472
SIC: 2834 Pharmaceutical Preparations